Newsletter

SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

  • 2026-10-27 05:15:40

Singapore's Health Sciences Authority (HSA) has introduced the submission window for the inaugural year of the Registration Support Initiative for unregistered medical device previously have been accessed through Special Access Routes (SAR) to 31 December 2026. This provides medical and dental practitioners and other stakeholders with additional time to prepare submissions, engage relevant parties and obtain the necessary endorsements. From 2027 onwards, the Initiative will follow a standard annual submission cycle from 1 October to 31 December.

More
SINGAPORE: HSA PUBLISHES FINALISED GL-10 R1 BEST PRACTICES GUIDE ON MEDICAL DEVICE CYBERSECURITY – September/October 2026

SINGAPORE: HSA PUBLISHES FINALISED GL-10 R1 BEST PRACTICES GUIDE ON MEDICAL DEVICE CYBERSECURITY – September/October 2026

  • 2026-10-27 04:39:09

Singapore's Health Sciences Authority (HSA) has published the finalised GL-10 R1 Best Practices Guide on Medical Device Cybersecurity following a public consultation conducted from 10 March to 13 May 2025. The guide provides best practice recommendations and considerations for managing cybersecurity risks associated with connected medical devices throughout the Total Product Life Cycle (TPLC). HSA also published a summary of responses to stakeholder feedback received during the consultation.

More
Philippines: PFDA Updates Draft Guidelines on Medical Device Labeling Requirements – September/October 2026

Philippines: PFDA Updates Draft Guidelines on Medical Device Labeling Requirements – September/October 2026

  • 2026-10-27 04:18:58

The Food and Drug Administration of the Philippines (PFDA) has released a draft FDA Circular proposing detailed guidelines for medical device labeling in the Philippines. The draft provides more specific requirements on labeling content and placement, device-specific labeling, electronic labeling, and regulatory actions for non-compliance. It also proposes a two-year transition period for medical devices already registered and available in the Philippine market. While the Circular remains in draft form, it reflects PFDA's direction toward more detailed and specific medical device labeling requirements.

More
Philippines: PFDA Circulates Revised Draft Regulatory Guidelines for Medical Device Software (MDSW) – September/October 2026

Philippines: PFDA Circulates Revised Draft Regulatory Guidelines for Medical Device Software (MDSW) – September/October 2026

  • 2026-10-26 09:52:44

The Food and Drug Administration of the Philippines (PFDA) has circulated a revised draft Circular proposing updated regulatory guidelines for Medical Device Software (MDSW), including AI-enabled MDSW. The draft outlines software qualification criteria, risk-based classification, product authorization pathways, and technical documentation requirements for initial and renewal applications. It also introduces AI-specific requirements covering clinical validation, cybersecurity, risk management, and post-market monitoring. The proposed guidelines aim to strengthen the safety and performance of MDSW throughout its lifecycle. The Circular remains in draft form and is not yet effective.

More
South Korea: Recent MFDS Regulatory Updates – Medical Device Adverse Event Reporting and KGMP – September/October 2026

South Korea: Recent MFDS Regulatory Updates – Medical Device Adverse Event Reporting and KGMP – September/October 2026

  • 2026-10-26 09:33:44

The Ministry of Food and Drug Safety (MFDS) of South Korea has recently revised regulations concerning medical device adverse event reporting and Korean Good Manufacturing Practice (KGMP) and introduced a new regulation governing the designation and management of organizations involved in medical device quality management.
These regulatory updates aim to clarify adverse event reporting requirements and timelines, while improving regulatory clarity by separating KGMP conformity assessment requirements from provisions governing assessment bodies and training organizations.
This newsletter provides an overview of three regulatory updates that took effect on July 1 and September 22, 2026.

More
Japan: A Brief Introduction to SaMD Application: FAQ – September/October 2026

Japan: A Brief Introduction to SaMD Application: FAQ – September/October 2026

  • 2026-10-26 09:17:04

This FAQ summarizes key regulatory resources and consultation opportunities relevant to the development and regulatory submission of Software as a Medical Device (SaMD) in Japan. The information is intended to support manufacturers in understanding regulatory expectations and planning efficient development and submission strategies throughout the product lifecycle.

More
Australia: TGA Issues Guidance on Media Coverage of Therapeutic Goods – September/October 2026

Australia: TGA Issues Guidance on Media Coverage of Therapeutic Goods – September/October 2026

  • 2026-10-26 09:03:49

The Therapeutic Goods Administration (TGA) has published detailed regulatory guidance to help journalists, media organizations, and sponsors distinguish genuine public-interest news reporting from therapeutic goods advertising. Under the Therapeutic Goods Act 1989, media content that promotes the supply or use of regulated products—either directly or indirectly—is subject to strict advertising rules, including prohibitions on public promotion of prescription-only medicines. This article explores the legal distinction between independent journalism and promotional content, key indicators of unlawful advertising in news formats, statutory exceptions for broadcasters and publishers, and practical case studies provided by the regulatory authority.

More
Qualtech Webinar: ASEAN Regulatory Briefing – Thailand & Malaysia – October 2026

Qualtech Webinar: ASEAN Regulatory Briefing – Thailand & Malaysia – October 2026

  • 2026-10-09 01:44:32

Qualtech invites you to our free webinar on Thursday, October 29, 2026, with the topic "ASEAN Regulatory Briefing: Thailand & Malaysia - Critical Updates Impacting Medical Device Market Access".
Our local regulatory experts from Thailand and Malaysia will share practical insights into the latest regulatory changes, updated requirements, and key considerations affecting medical device registration and regulatory compliance. This session is highly recommended for all medical device manufacturers currently active in, or planning to enter, the Thailand and Malaysian market.

More
China's Bariatric and Metabolic Surgery Market: Demand, Policy and Device Trends – August/September 2026

China's Bariatric and Metabolic Surgery Market: Demand, Policy and Device Trends – August/September 2026

  • 2026-09-21 05:48:49

China's obesity burden continues to rise, with about 57% of adults overweight / obese and the rate projected to reach 70.5% by 2030. At the same time, nearly 970 hospitals are estimated to be involved in bariatric and metabolic surgery nationwide, while China's bariatric surgery market is projected to grow from US$207M in 2026 to nearly US$398M by 2031. This article reviews the latest policy, clinical and market developments shaping opportunities in China's obesity-treatment and minimally invasive surgery sectors.

More